Clinical Trial Update: An Efficacy and Safety Study of Decitabine in Participants With Myelodysplastic Syndrome (MDS) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy and safety of decitabine in participants with myelodysplastic syndrome has completed and results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Drugs mentioned

• Decitabine (Decitabine)

Snippet

Sponsor: Johnson & Johnson Taiwan Ltd | Conditions: Myelodysplastic Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2013-08-15